Found: 66
Select item for more details and to access through your institution.
The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1448709
- By:
- Publication type:
- Article
Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma.
- Published in:
- Frontiers of Medicine, 2020, v. 14, n. 6, p. 711, doi. 10.1007/s11684-020-0808-3
- By:
- Publication type:
- Article
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32960-3
- By:
- Publication type:
- Article
Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.
- Published in:
- Mycopathologia, 2016, v. 181, n. 9/10, p. 753, doi. 10.1007/s11046-016-0030-7
- By:
- Publication type:
- Article
Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 4, p. 3321, doi. 10.1007/s00520-021-06639-2
- By:
- Publication type:
- Article
γδ T cell and other immune cells crosstalk in cellular immunity.
- Published in:
- 2014
- By:
- Publication type:
- journal article
γδ T Cell and Other Immune Cells Crosstalk in Cellular Immunity.
- Published in:
- Journal of Immunology Research, 2014, p. 1, doi. 10.1155/2014/960252
- By:
- Publication type:
- Article
Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.965224
- By:
- Publication type:
- Article
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 490, doi. 10.3390/curroncol29020044
- By:
- Publication type:
- Article
Survival and late mortality among patients who survived disease‐free for 2 years after stem cell transplantation.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 3, p. 608, doi. 10.1111/bjh.18905
- By:
- Publication type:
- Article
Generation of hematopoietic cells from mouse pluripotent stem cells in a 3D culture system of self‐assembling peptide hydrogel.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 3, p. 2080, doi. 10.1002/jcp.29110
- By:
- Publication type:
- Article
Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1429, doi. 10.1002/ajh.26317
- By:
- Publication type:
- Article
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma.
- Published in:
- Cell Transplantation, 2023, v. 32, p. 1, doi. 10.1177/09636897231194265
- By:
- Publication type:
- Article
Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies.
- Published in:
- Cell Transplantation, 2021, v. 30, p. 1, doi. 10.1177/09636897211025503
- By:
- Publication type:
- Article
Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies.
- Published in:
- Cell Transplantation, 2020, v. 29, p. 1, doi. 10.1177/0963689720919434
- By:
- Publication type:
- Article
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0070-9
- By:
- Publication type:
- Article
Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.702152
- By:
- Publication type:
- Article
Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1462, doi. 10.4143/crt.2017.473
- By:
- Publication type:
- Article
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Efficient Commitment to Functional CD34+ Progenitor Cells from Human Bone Marrow Mesenchymal Stem-Cell-Derived Induced Pluripotent Stem Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034321
- By:
- Publication type:
- Article
CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 9, p. 1499, doi. 10.1007/s00277-014-2069-1
- By:
- Publication type:
- Article
Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 11, p. 1803, doi. 10.1007/s00277-012-1505-3
- By:
- Publication type:
- Article
Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00375-3
- By:
- Publication type:
- Article
Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01534
- By:
- Publication type:
- Article
Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)‐T cell therapy in patients with hematological malignancy.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 257, doi. 10.1111/ejh.14099
- By:
- Publication type:
- Article
Donor‐derived stem cell infusion for sustained pancytopenia after CD19 CAR‐T therapy for relapsed patients post allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 1, p. 94, doi. 10.1111/ejh.14050
- By:
- Publication type:
- Article
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11540-8
- By:
- Publication type:
- Article
CAR-T Cell Therapy: Advances in Kidney-Related Diseases.
- Published in:
- Kidney Diseases, 2024, v. 10, n. 2, p. 143, doi. 10.1159/000536194
- By:
- Publication type:
- Article
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti‐Leukemia Efficacy of CAR‐T Cells via SOCE‐Calcineurin‐NFAT and Glycolysis Pathways.
- Published in:
- Advanced Science, 2022, v. 9, n. 9, p. 1, doi. 10.1002/advs.202103508
- By:
- Publication type:
- Article
Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.755584
- By:
- Publication type:
- Article
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.750218
- By:
- Publication type:
- Article
Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.713577
- By:
- Publication type:
- Article
New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.702644
- By:
- Publication type:
- Article
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1125357
- By:
- Publication type:
- Article
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09893-x
- By:
- Publication type:
- Article
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019.
- Published in:
- 2021
- By:
- Publication type:
- journal article
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 2, p. 129, doi. 10.20892/j.issn.2095-3941.2022.0585
- By:
- Publication type:
- Article
Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.627764
- By:
- Publication type:
- Article
Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Letter
A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Acute lymphoblastic leukemia relapse after CD19‐targeted chimeric antigen receptor T cell therapy.
- Published in:
- Journal of Leukocyte Biology, 2017, v. 102, n. 6, p. 1347, doi. 10.1189/jlb.5RU0817-315R
- By:
- Publication type:
- Article
Rapid mobilization of fully functional natural killer cells into blood by AMD3100.
- Published in:
- Transfusion, 2013, v. 53, n. 9, p. 2108, doi. 10.1111/trf.12306
- By:
- Publication type:
- Article
Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article